Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals
The COVID-19 pandemic highlights the need for novel antiviral drug discovery approaches that could dramatically shorten timelines from compound discovery to clinical development. At the beginning of the pandemic, repurposing approaches were at the forefront of early research efforts to screen for an...
Principais autores: | Brun, J, Arman, BY, Hill, ML, Kiappes, JL, Alonzi, DS, Makower, LL, Witt, KD, Gileadi, C, Rangel, V, Dwek, RA, Von Delft, A, Zitzmann, N |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2025
|
Registros relacionados
-
Iminosugar antivirals: the therapeutic sweet spot
por: Alonzi, D, et al.
Publicado em: (2017) -
Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells
por: Perera, N, et al.
Publicado em: (2022) -
Antiviral effects of an iminosugar derivative on flavivirus infections.
por: Wu, S, et al.
Publicado em: (2002) -
Mechanisms of antiviral activity of iminosugars against dengue virus
por: Miller, JL, et al.
Publicado em: (2018) -
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
por: Warfield, KL, et al.
Publicado em: (2016)